Abdulghani J, Gokare P, Gallant JN, et al. Sorafenib and quinacrine target anti-apoptotic protein Mcl-1: a poor prognostic marker in anaplastic thyroid cancer (ATC). Clin Cancer Res. 2016.
Alolod GP, Traino HM, Siminoff LA. Utility and Usability of the Rapid Assessment of Hospital Procurement Barriers in Donation (RAPiD) as a Tool for OPO Hospital Development Staff. Prog Transplant. 2016.
Barta SK, Li H, Hochster HS, et al. Randomized phase 3 study in low-grade lymphoma comparing maintenance anti-CD20 antibody with observation after induction therapy: A trial of the ECOG-ACRIN Cancer Research Group (E1496). Cancer. 2016.
Bass SB, Gordon TF, Gordon R, Parvanta C. Using eye tracking and gaze pattern analysis to test a “dirty bomb” decision aid in a pilot RCT in urban adults with limited literacy. BMC Med Inform Decis Mak. 2016;16(1):67.
Beitler JJ, Quon H, Jones CU, et al. ACR Appropriateness Criteria(R) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas. Head Neck. 2016.
Cahn DB, Ristau BT, Ghiraldi EM, et al. Bladder Preservation Therapy: A Review of the Literature and Future Directions. Urology. 2016.
Chambers SK, Foley E, Clutton S, et al. The role of mindfulness in distress and quality of life for men with advanced prostate cancer. Qual Life Res. 2016.
Chang EI, Bradley JP. Reply: Additional Insights Regarding Virtual Surgical Planning for Osteocutaneous Free Flap Mandible Reconstruction. Plast Reconstr Surg. 2016.
Chwistek M, Ewerth N. Opioids and Chronic Pain in Cancer Survivors: Evolving Practice for Palliative Care Clinics. J Palliat Med. 2016;19(3):254.
Denlinger CS, Ligibel JA, Are M, et al. NCCN Guidelines Insights: Survivorship, Version 1.2016. J Natl Compr Canc Netw. 2016;14(6):715-724.
Devarajan K, Cheung VC. A Quasi-Likelihood Approach to Nonnegative Matrix Factorization. Neural Comput. 2016:1-31.
Duivenvoorden WC, Daneshmand S, Canter D, et al. Incidence, characteristics, and implications of thromboembolic events in patients with muscle-invasive urothelial carcinoma of the bladder undergoing neoadjuvant chemotherapy. J Urol. 2016.
Forman ME, Jennings MC, Wuest WM, Minbiole KP. Building a Better Quaternary Ammonium Compound (QAC): Branched Tetracationic Antiseptic Amphiphiles. ChemMedChem. 2016.
Franco-Barraza J, Beacham DA, Amatangelo MD, Cukierman E. Preparation of Extracellular Matrices Produced by Cultured and Primary Fibroblasts. Curr Protoc Cell Biol. 2016;71:10 19 11-10 19 34.
Gaponova AV, Nikonova A, Deneka AY, et al. A novel HSP90 inhibitor-drug conjugate to SN38 is highly effective in small cell lung cancer (SCLC). Clin Cancer Res. 2016.
Gettinger S, Rizvi NA, Chow LQ, et al. Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer. J Clin Oncol. 2016.
Gor RA, Styskel BA, Li T, Canter DJ, Simhan J. Unexpected High Rates of Angiography and Angioembolization for Isolated Low Grade Renal Trauma: Results from a Large, Statewide, Trauma Database. Urology. 2016.
Jain R, Savage MJ, Forman AD, Mukherji R, Hall MJ. The Relevance of Hereditary Cancer Risks to Precision Oncology: What Should Providers Consider When Conducting Tumor Genomic Profiling? J Natl Compr Canc Netw. 2016;14(6):795-806.
Katz MH, Shi Q, Ahmad SA, et al. Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101. JAMA Surg. 2016:e161137.
Kent T, Mateos-Gomez PA, Sfeir A, Pomerantz RT. Polymerase theta is a robust terminal transferase that oscillates between three different mechanisms during end-joining. Elife. 2016;5.
Kuang J, Li L, Guo L, et al. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells. J Exp Clin Cancer Res. 2016;35(1):88.
Kudinov AE, Deneka A, Nikonova AS, et al. Musashi-2 (MSI2) supports TGF-beta signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis. Proc Natl Acad Sci U S A. 2016;113(25):6955-6960.
Lesokhin AM, Ansell SM, Armand P, et al. Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study. J Clin Oncol. 2016.
Lieberman D, Rex D, Kochman M, Tokar J. Diminutive Colon Polyps Reply. Clinical Gastroenterology and Hepatology. 2016;14(6):916-918.
Liu D, Plimack ER, Hoffman-Censits J, et al. Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma. JAMA Oncol. 2016.
Malouf GG, Su X, Zhang J, et al. DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas. Clin Cancer Res. 2016.
Meeker CR, Geynisman DM, Egleston BL, et al. Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With Cancer. J Oncol Pract. 2016.
Miller-Halegoua S, Bowen DJ, Diefenbach MA, Tercyak KP. Creating the future of translational behavioral medicine. Transl Behav Med. 2016;6(2):167-168.
Monteith JA, Mellert H, Sammons MA, et al. A rare DNA contact mutation in cancer confers p53 gain-of-function and tumor cell survival via TNFAIP8 induction. Mol Oncol. 2016.
Nicolas E, Golemis EA, Arora S. POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies. Gene. 2016;590(1):128-141.
Nogusa S, Thapa RJ, Dillon CP, et al. RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus. Cell Host Microbe. 2016.
Ohar JA, Cheung M, Talarchek J, et al. Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer. Cancer Res. 2016;76(2):206-215.
Patel B, Patel J, Cho JH, et al. Exosomes mediate the acquisition of the disease phenotypes by cells with normal genome in tuberous sclerosis complex. Oncogene. 2016;35(23):3027-3036.
Pilarski R, Daly M. The authors’ reply. JNCCN Journal of the National Comprehensive Cancer Network. 2016;14(5):1-li.
Renault AL, Lesueur F, Coulombe Y, et al. ABRAXAS (FAM175A) and breast cancer susceptibility: No evidence of association in the breast cancer family registry. PLoS ONE. 2016;11(6):3.
Rizvi NA, Hellmann MD, Brahmer JR, et al. Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer. J Clin Oncol. 2016.
Ruggieri DG, Bass SB. African-American Parents’ Knowledge and Perceptions About BMI Measurements, School-Based BMI Screening Programs, and BMI Report Cards: Results from a Qualitative Investigation and Implications for School-to-Parent Communication. J Racial Ethn Health Disparities. 2016;3(2):320-330.
Sariyer IK, Sariyer R, Otte J, Gordon J. Pur-Alpha Induces JCV Gene Expression and Viral Replication by Suppressing SRSF1 in Glial Cells. PLoS One. 2016;11(6):e0156819.
Schiech L. Tonsillar cancer: What nurses need to know. Nursing. 2016;46(7):36-44.
Seiwert TY, Burtness B, Mehra R, et al. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. Lancet Oncol. 2016.
Seki M, LaCanna R, Powers JC, et al. Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation. J Pharmacol Exp Ther. 2016.
Simonelli M, Zucali P, Santoro A, et al. Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase 1 in patients with hepatocellular carcinoma. Ann Oncol. 2016.
Sykes SM. The identity crisis of Hif-1alpha in HSC biology. Blood. 2016;127(23):2782-2784.
Terry MB, Goldberg M, Schechter S, et al. Comparison of Clinical, Maternal, and Self Pubertal Assessments: Implications for Health Studies. Pediatrics. 2016.
Wang EH, Yu JB, Abouassally R, et al. Disparities in Treatment of Patients with High-Risk Prostate Cancer: Results From A Population-Based Cohort. Urology. 2016.
Wang X, Li M, Gao Y, et al. Rheb1-mTORC1 maintains macrophage differentiation and phagocytosis in mice. Exp Cell Res. 2016;344(2):219-228.
Wang Y, Bernhardy AJ, Cruz C, et al. The BRCA1-Δ11q alternative splice isoform bypasses germline mutations and promotes therapeutic resistance to PARP inhibition and cisplatin. Cancer Research. 2016;76(9):2778-2790.
Wang Y, Cai KQ, Smith ER, et al. Follicle Depletion Provides A Permissive Environment for Ovarian Carcinogenesis. Mol Cell Biol. 2016.
Warner SG, Haddad D, Au J, et al. Oncolytic herpes simplex virus kills stem-like tumor-initiating colon cancer cells. Mol Ther Oncolytics. 2016;3:16013.
Xie L, Gu Y, Wen M, et al. Hydrogen sulfide induces keap1 S-sulfhydration and suppresses diabetes-accelerated atherosclerosis via Nrf2 activation. Diabetes. 2016.
Zaorsky NG, Egleston BL, Horwitz EM, et al. The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate Cancer. Am J Clin Oncol. 2016.
Zaorsky NG, Shaikh T, Murphy CT, et al. Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer. Cancer Treat Rev. 2016;48:50-60.
Zhang RX, Wong HL, Xue HY, Eoh JY, Wu XY. Nanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives. J Control Release. 2016.
Zhao S, Teijaro C, Chen H, et al. Concise Syntheses of Bis-Strychnos Alkaloids (-)-Sungucine, (-)-Isosungucine, and (-)-Strychnogucine B from (-)-Strychnine. Chemistry. 2016.
Zibelman M, Ghatalia P, Geynisman DM, Plimack ER. Checkpoint inhibitors for renal cell carcinoma: current landscape and future directions. Immunotherapy. 2016;8(7):785-798.
Zong JC, Heaggans SY, Long SY, et al. Detection of quiescent infections with multiple elephant endotheliotropic herpesviruses (EEHVs), including EEHV2, EEHV3, EEHV6, and EEHV7, within lymphoid lung nodules or lung and spleen tissue samples from five asymptomatic adult African elephants. Journal of Virology. 2016;90(6):3028-3043.